{"data":{"id":"us-la/rs-40-1258.1","jurisdiction":"us-la","citation":"RS 40:1258.1","heading":"Definitions","body":"As used in this Part, the following terms have the meanings ascribed to them in this Section:\n(1) \"Chimeric antigen receptor (CAR) T-cell therapy\" means a treatment that is designed to manipulate T-cell protein to recognize an antigen on targeted tumor cells in an effort to eliminate cancer.\n(2) \"Healthcare facility\" has the same meaning as the term is defined in R.S. 40:2120.13.","path":["TITLE 40. PUBLIC HEALTH AND SAFETY","PART VII. CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY"],"source_url":"https://www.legis.la.gov/legis/Law.aspx?d=1336073","current_through":"2025 First Extraordinary Session","vintage":"","retrieved_at":"2026-09-14T05:00:52Z","sha256":"12ef566ad779eab0dfd819dea37df8f9c348a8da68541eb639e966826ba1a9ba","source_id":"us-la","stale":false,"prev":"us-la/rs-40-1257.5","next":"us-la/rs-40-1258.2"},"notice":"GroundRules: Original legal text. Not legal advice."}